A Novel Stool PCR Test for Helicobacter pylori May Predict Clarithromycin Resistance and Eradication of Infection at a High Rate

Clarithromycin-based regimens are commonly used as a first-line therapy for Helicobacter pylori-positive patients; however, resistance to clarithromycin has led to treatment failures. The aim of this study was to evaluate the feasibility of using stool samples to detect the presence of H. pylori DNA...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Microbiol
Autors principals: Beckman, Erin, Saracino, Ilaria, Fiorini, Giulia, Clark, Courtney, Slepnev, Vladimir, Patel, Denise, Gomez, Clarissa, Ponaka, Reddy, Elagin, Vecheslav, Vaira, Dino
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Bacteriology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527417/
https://ncbi.nlm.nih.gov/pubmed/28515219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.00506-17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars